NCT04788797View on ClinicalTrials.gov

AN-PEP on Gluten Exposure in Celiacs

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 17, 2021

Primary Completion Date

July 30, 2022

Study Completion Date

July 31, 2022

Conditions
Celiac Disease
Interventions
DRUG

Prolyl Endopeptidase

Two capsules three times a day.

OTHER

Placebo

Two capsules three times a day

Trial Locations (1)

1602

Dr. C. Bonorino Udaondo Gastroenterology Hospital, Ciudad Autonoma de Buenos Aires

All Listed Sponsors
lead

Dr. C. Bonorino Udaondo Gastroenterology Hospital

OTHER_GOV

NCT04788797 - AN-PEP on Gluten Exposure in Celiacs | Biotech Hunter | Biotech Hunter